These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12502881)

  • 1. Transcription initiation activity of adenovirus left-end sequence in adenovirus vectors with e1 deleted.
    Yamamoto M; Davydova J; Takayama K; Alemany R; Curiel DT
    J Virol; 2003 Jan; 77(2):1633-7. PubMed ID: 12502881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional repression of the E2 transcription unit in E1-E3-deleted adenovirus vectors is correlated with a strong reduction in viral DNA replication and late gene expression in vitro.
    Rittner K; Schultz H; Pavirani A; Mehtali M
    J Virol; 1997 Apr; 71(4):3307-11. PubMed ID: 9060700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral vectors stimulate glucagon transcription in human mesenchymal stem cells expressing pancreatic transcription factors.
    Zaldumbide A; Carlotti F; Gonçalves MA; Knaän-Shanzer S; Cramer SJ; Roep BO; Wiertz EJ; Hoeben RC
    PLoS One; 2012; 7(10):e48093. PubMed ID: 23110179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
    Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
    Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors.
    Everett RS; Hodges BL; Ding EY; Xu F; Serra D; Amalfitano A
    Hum Gene Ther; 2003 Dec; 14(18):1715-26. PubMed ID: 14670123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector.
    Wang Q; Greenburg G; Bunch D; Farson D; Finer MH
    Gene Ther; 1997 May; 4(5):393-400. PubMed ID: 9274715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.
    Amalfitano A; Hauser MA; Hu H; Serra D; Begy CR; Chamberlain JS
    J Virol; 1998 Feb; 72(2):926-33. PubMed ID: 9444984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses.
    Imler JL; Bout A; Dreyer D; Dieterlé A; Schultz H; Valerio D; Mehtali M; Pavirani A
    Hum Gene Ther; 1995 Jun; 6(6):711-21. PubMed ID: 7548271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a packaging cell line for propagation of replication-deficient adenovirus vector.
    Kim JS; Lee SH; Cho YS; Park K; Kim YH; Lee JH
    Exp Mol Med; 2001 Sep; 33(3):145-9. PubMed ID: 11642550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors.
    Mizuguchi H; Kay MA
    Hum Gene Ther; 1999 Aug; 10(12):2013-7. PubMed ID: 10466635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.
    Kuzmin AI; Galenko O; Eisensmith RC
    Mol Ther; 2001 Mar; 3(3):293-301. PubMed ID: 11273770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology of E1-deleted adenovirus vectors in nonhuman primate muscle.
    Zoltick PW; Chirmule N; Schnell MA; Gao GP; Hughes JV; Wilson JM
    J Virol; 2001 Jun; 75(11):5222-9. PubMed ID: 11333904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
    Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
    Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors.
    Amalfitano A; Begy CR; Chamberlain JS
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3352-6. PubMed ID: 8622940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted.
    Zhou H; O'Neal W; Morral N; Beaudet AL
    J Virol; 1996 Oct; 70(10):7030-8. PubMed ID: 8794347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy.
    Gao GP; Yang Y; Wilson JM
    J Virol; 1996 Dec; 70(12):8934-43. PubMed ID: 8971023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein.
    Hodges BL; Serra D; Hu H; Begy CA; Chamberlain JS; Amalfitano A
    J Gene Med; 2000; 2(4):250-9. PubMed ID: 10953916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
    Lanuti M; Gao GP; Force SD; Chang MY; El Kouri C; Amin KM; Hughes JV; Wilson JM; Kaiser LR; Albelda SM
    Hum Gene Ther; 1999 Feb; 10(3):463-75. PubMed ID: 10048398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degenerated pIX-IVa2 adenoviral vector sequences lowers reacquisition of the E1 genes during virus amplification in 293 cells.
    Robert JJ; Gauffeny I; Maccario J; Jullien C; Benoit P; Vigne E; Crouzet J; Perricaudet M; Yeh P
    Gene Ther; 2001 Nov; 8(22):1713-20. PubMed ID: 11892839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.